Patrick A. Ott

1. Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
   2021/01/20 by Eryn Blass, Patrick A. Ott · 16 citations
   Immunology and Microbiology · Medicine · #CAR-T cell therapy research #Cancer Immunotherapy and Biomarkers #Immunotherapy and Immune Responses
2. A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
   2020/10/01 by Patrick A. Ott, Siwen Hu‐Lieskovan, Siwen Hu-Lieskovan +44 · 11 citations
   Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Cancer Immunotherapy and Biomarkers #Immunotherapy and Immune Responses #vaccines and immunoinformatics approaches
3. A phase 2 study of glembatumumab vedotin, an antibody‐drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma
   2019/01/28 by Patrick A. Ott, Anna C. Pavlick, Douglas B. Johnson +20 · 27 citations
   Medicine · Biochemistry, Genetics and Molecular Biology · #Cutaneous Melanoma Detection and Management #HER2/EGFR in Cancer Research #Melanoma and MAPK Pathways